Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • CUBIST PHARMACEUTICALS INC Financial Overview

  • Income Statement: CBST
      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 433.64 M 294.62 M 139.02 M 32.06%
    Gross Profit 343.26 M 218.59 M 124.67 M 36.32%
    Net Income Before Extra Items/Preferred Div 169.82 M 48.15 M 121.67 M 71.65%
    Operating Income 93.19 M 41.44 M 51.75 M 55.53%
    View Full Report

  • Cash Flow: CBST
      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing -32.42 M 11.83 M -44.25 M 136.48%
    Net Cash Flow - Investing 35.53 M -226.16 M 261.69 M 736.60%
    Net Cash Flow/Operating Activities 122.19 M 100.77 M 21.42 M 17.53%
    View Full Report

  • Balance Sheet: CBST

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 635.21 M 534.52 M 100.70 M 15.85%
    Total Liabilities 323.24 M 435.81 M -112.58 M -34.83%
    Shareholders Equity 311.97 M 98.70 M 213.27 M 68.36%
    View Full Report

  • Key Ratios / Statistics: CBST

    • Valuation

      Price/Earnings (TTM) 9.44
      Price/Sales (TTM) 3.79
      Price/Book (MRQ) 2.66
      Price/Cash Flow (TTM) 7.37

    • Profitability

      Gross Margin 79.16
      Operating Margin 21.49
      Profit Margin 39.16

    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00

    • Financial Strength

      Quick Ratio (MRQ) 5.55
      Current Ratio (MRQ) 8.28
      Long Term Debt-to-Equity (MRQ) 55.11

    • Management Effectiveness

      Return on Equity (TTM) 73.19
      Return on Assets (TTM) 29.82
      Return on Investments (TTM) 33.17
    View All Key Ratios